The new vaccine is scheduled to enter experiments in Hong Kong in November, and the vaccine will not need to obtain regulatory approval for several months in order to start using it if it is proven successful.
Yuen Kwok Young, department head said Infectious diseases In the Department of Microbiology at the University of Hong Kong, which is participating in the study, the first phase of the experiments will start in Hong Kong, and about 100 adults will be registered for completion.
“Our idea is that we want to protect against influenza and Covid-19 at the same time,” Yuen said in statements to Bloomberg.
The new vaccine is used Influenza virus Weak only grows in the upper airway. The attenuated virus cannot reproduce, and it has been genetically engineered to include the coronavirus protein.
And if the new vaccine is successful, it will lead to an immune response against the Corona virus, as the immune system must produce antibodies equivalent to this high protein, which prevents the real virus from reproducing.
The new vaccine prompts the immune system to generate antibodies that respond to the influenza virus that was used in the vaccine. However, other influenza viruses may still be contagious.
“It has been shown that the vaccine works well in animals,” Yuen said. He added, “I think that Mucous membrane vaccine Great idea, “he said, referring to spray vaccines that target the nasal mucosa.
These were the details of the news Two in one … Scientists develop a vaccine against Corona and... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at eg24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
